1. Home
  2. TLSI vs SORA Comparison

TLSI vs SORA Comparison

Compare TLSI & SORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSI
  • SORA
  • Stock Information
  • Founded
  • TLSI 2010
  • SORA 2001
  • Country
  • TLSI United States
  • SORA Hong Kong
  • Employees
  • TLSI N/A
  • SORA N/A
  • Industry
  • TLSI Medical Specialities
  • SORA Other Specialty Stores
  • Sector
  • TLSI Health Care
  • SORA Industrials
  • Exchange
  • TLSI Nasdaq
  • SORA Nasdaq
  • Market Cap
  • TLSI 204.0M
  • SORA 174.8M
  • IPO Year
  • TLSI N/A
  • SORA 2025
  • Fundamental
  • Price
  • TLSI $4.56
  • SORA $6.60
  • Analyst Decision
  • TLSI Strong Buy
  • SORA
  • Analyst Count
  • TLSI 5
  • SORA 0
  • Target Price
  • TLSI $10.90
  • SORA N/A
  • AVG Volume (30 Days)
  • TLSI 134.8K
  • SORA 75.6K
  • Earning Date
  • TLSI 08-13-2025
  • SORA 01-01-0001
  • Dividend Yield
  • TLSI N/A
  • SORA N/A
  • EPS Growth
  • TLSI N/A
  • SORA N/A
  • EPS
  • TLSI N/A
  • SORA N/A
  • Revenue
  • TLSI $32,141,000.00
  • SORA $17,619,363.00
  • Revenue This Year
  • TLSI $55.39
  • SORA N/A
  • Revenue Next Year
  • TLSI $54.89
  • SORA N/A
  • P/E Ratio
  • TLSI N/A
  • SORA N/A
  • Revenue Growth
  • TLSI 46.20
  • SORA N/A
  • 52 Week Low
  • TLSI $3.50
  • SORA $5.30
  • 52 Week High
  • TLSI $6.04
  • SORA $14.15
  • Technical
  • Relative Strength Index (RSI)
  • TLSI 39.21
  • SORA N/A
  • Support Level
  • TLSI $4.41
  • SORA N/A
  • Resistance Level
  • TLSI $4.73
  • SORA N/A
  • Average True Range (ATR)
  • TLSI 0.22
  • SORA 0.00
  • MACD
  • TLSI -0.02
  • SORA 0.00
  • Stochastic Oscillator
  • TLSI 18.99
  • SORA 0.00

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

About SORA Top Win International Limited Ordinary Shares

Top Win International Ltd is a wholesaler engaged in trading, distribution, and retail of luxury watches of international brands. The Group sources its luxury watches from Europe, Singapore, Japan, and Hong Kong, then sells the goods to retail sellers and other distributors in the watch industry.

Share on Social Networks: